ARTHUR MCKINISH: Open Payments
NPI 1972185999 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 59 payments from 14 companies in 2025. Trend: 2023 $811 · 2024 $1,221 · 2025 $1,178
Food & beverage: $1,176Education: $2
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 9 | $198 |
| Fresenius USA Marketing, Inc. | 10 | $181 |
| Vifor Pharma, Inc. | 7 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| Ardelyx, Inc. | 5 | $100 |
| Amgen Inc. | 5 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: VELPHORO, Veltassa, JYNARQUE, IBSRELA, Fabhalta, TAVNEOS, Kerendia, FARXIGA.
Industry payments across GA — which companies pay providers there.
